Trial intelligence / Profile preview

Dopamine Transmission in Prenatal Cocaine Exposure

NCT03606473Phase 1Completed

Start
Jan 2018
Primary completion
Aug 2020
Countries
1
01

Overview

Phase 1, open-label trial (2 arms). Primary endpoint: Percent change in Binding potential (BPnd) at 3 hours. Started Jan 2018; status: completed.

Beyond the preview

Go deeper on NCT03606473.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03606473.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call